BioBridgeXAll companies

Thrombolex, Inc.

Biotechnology company · New Britian, Pennsylvania, United States

Thrombolex, Inc. is a biotechnology company headquartered in New Britian, Pennsylvania, United States. The US FDA lists 1 medical device site registered to the company, with devices in cardiovascular. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $3 million in total, most recently in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Thrombolex at a glance

Typebiotechnology company
HeadquartersNew Britian, Pennsylvania, United States
FDA-registered sites1
Employees (self-reported, 2020)5

What does Thrombolex do?

Medical specialties of its FDA-listed devices

Cardiovascular

Device types listed with the FDA

Mechanical thrombolysis catheterCatheter, continuous flush

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $3 million in total (2020). NIH funding came from the National Heart, Lung, and Blood Institute.

Where is Thrombolex located?

Headquarters: New Britian, Pennsylvania, United States

  • New Britain, PennsylvaniaThrombolex, Inc. · FDA device site

Frequently asked questions about Thrombolex

Where is Thrombolex headquartered?

Thrombolex, Inc. is headquartered in New Britian, Pennsylvania, United States.

What does Thrombolex do?

Thrombolex, Inc. is a biotechnology company. Its FDA-listed medical devices fall under cardiovascular.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences